Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
39.55
-1.68 (-4.07%)
At close: Sep 10, 2026, 4:00 PM EDT
40.25
+0.70 (1.77%)
Pre-market: Sep 11, 2026, 7:54 AM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.82 billion as of September 10, 2026. Its market cap has increased by 130.43% in one year.
Market Cap
2.82B
Enterprise Value
1.48B
1-Year Change
130.43%
Ranking
Category
Stock Price
$39.55
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.82B, an increase of 413.88%. That is a compound annual growth rate of 57.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 2.82B | -41.35% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| uniQure | 3.19B |
| Celldex Therapeutics | 3.05B |
| MBX Biosciences | 3.03B |
| Arcutis Biotherapeutics | 3.00B |
| Immunome | 2.97B |
| Disc Medicine | 2.94B |
| SELLAS Life Sciences Group | 2.82B |
| Zai Lab | 2.82B |